Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07291609Recruiting

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

Role: collaborator

NCT06965023Recruiting

Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)

Role: collaborator

NCT06793111Recruiting

Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)

Role: collaborator

NCT06119633Not ApplicableCompleted

Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy

Role: collaborator

NCT05637788Active Not Recruiting

Artificial Intelligence and Hepatocellular Carcinoma

Role: collaborator

NCT04741178Unknown

PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis

Role: lead

NCT04348084Completed

Oncologic Impact of Pancreatic Fistula

Role: collaborator

All 7 trials loaded